# MOTS-C vs GHK-Cu for Muscle Building Over 50: Which Peptide Should You Choose?
If you're over 50 and serious about lifting, you've probably come across both MOTS-C and GHK-Cu. They're both well-researched peptides popular in the biohacking community — but they target completely different biological pathways.
Choosing between them depends on what your body needs most. Here's a clear breakdown.
---
The Core Problem: Why Muscle Gets Harder After 50
Two separate processes accelerate after age 40–50 that make building and preserving muscle significantly harder:
1. Mitochondrial decline. Mitochondria — your cells' energy factories — become less efficient with age. You produce less ATP per unit of effort, which means reduced endurance, lower training capacity, and slower recovery. This is partly driven by declining NAD+ levels and impaired mitochondrial biogenesis.
2. Connective tissue degradation. Collagen synthesis slows. Tendons and ligaments become less resilient. Recovery from training stress takes longer. Joint soreness becomes a limiting factor for many lifters over 50.
These aren't the same problem — and MOTS-C vs GHK-Cu targets each one differently.
---
What MOTS-C Does
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a mitochondria-derived peptide. Its primary function is mitochondrial regulation and metabolic optimization.
Key mechanisms:
- Activates AMPK (the body's master metabolic switch)
- Restores mitochondrial efficiency — more ATP produced per unit of substrate
- Improves fat oxidation at aerobic paces (better fuel usage during training)
- Enhances insulin sensitivity
- Upregulates stress response pathways
- More cellular energy available during training
- Better endurance and output across a 5-day training week
- Improved fat-to-muscle composition (body recomp effect)
- Supports lean mass preservation during caloric restriction
- Stimulates collagen and elastin synthesis
- Activates anti-inflammatory signaling pathways
- Promotes tissue repair and wound healing
- Upregulates genes associated with cellular protection
- Supports extracellular matrix repair
- Faster recovery from training-induced tissue stress
- Stronger tendons and ligaments over time
- Reduced joint inflammation
- Improved skin quality (significant cosmetic effect)
- Better soft tissue repair around muscle insertions
- Mitochondrial decline limiting energy and output → MOTS-C addresses this
- Higher connective tissue stress from heavy volume → GHK-Cu addresses this
- MOTS-C: 500mcg daily, morning (subQ)
- GHK-Cu: 1–2mg daily, any time (subQ)
- Optional add: Tesamorelin 1mg daily for GH axis support and visceral fat reduction
- NMN/NAD+ provides the raw substrate for mitochondrial reactions
- MOTS-C improves the efficiency of how mitochondria use that substrate
What this means for lifters over 50:
Research in aged animal models shows MOTS-C restores exercise capacity close to younger baselines. Human research is still emerging but the community data is consistent with the animal literature.
Standard dosing: 500mcg–1mg daily, subcutaneous injection, morning or pre-workout.
---
What GHK-Cu Does
GHK-Cu (copper peptide glycine-histidine-lysine) is a naturally occurring tripeptide that declines significantly with age. At 20 years old, you have roughly 200ng/mL in your blood. By 60, that's dropped to about 80ng/mL.
Key mechanisms:
What this means for lifters over 50:
GHK-Cu doesn't directly build muscle the way anabolic peptides do — but it makes your body a better environment for training to work. Heavy lifting breaks down tissue. GHK-Cu accelerates the repair side of that equation.
Standard dosing: 1–2mg daily, subcutaneous injection.
---
Head-to-Head: Which One Wins for Muscle Performance?
| Goal | MOTS-C | GHK-Cu |
| Cellular energy (ATP) | ✅ Primary mechanism | ❌ Not its job |
| Training endurance/output | ✅ Direct benefit | ❌ Indirect |
| Body recomposition | ✅ Strong evidence | ❌ Indirect |
| Collagen/tendon repair | ❌ Not its job | ✅ Primary mechanism |
| Anti-inflammatory | Partial | ✅ Strong |
| Recovery from heavy training | Partial (energy) | ✅ Direct |
| Skin quality | ❌ | ✅ |
If you're choosing one and your primary goal is gym performance — more energy, better strength output, improved body composition — MOTS-C wins.
If you're choosing one and you're dealing with joint issues, recovery time, or connective tissue problems that limit your training, GHK-Cu wins.
---
Why Most Serious Lifters Over 50 Run Both
The good news: these peptides work through completely different pathways, which means they stack without interference and are actually complementary.
A 52-year-old lifting heavy 5 days a week faces both problems simultaneously:
Running them together means you're improving energy production AND the repair capacity that heavy training demands. The two effects reinforce each other: you can train harder (MOTS-C), and recover better from harder training (GHK-Cu).
Sample stack for active lifters over 50:
---
What About NMN/NAD+ With MOTS-C?
MOTS-C and NMN (or direct NAD+ precursors) stack well. Both support mitochondrial function through overlapping but distinct pathways:
Together they're more effective than either alone for the mitochondrial decline that accelerates muscle loss after 50. If you're running MOTS-C, adding NMN (500mg–1g daily) is a reasonable next step.
---
Frequently Asked Questions
Q: Can I inject MOTS-C and GHK-Cu at the same time?
A: Yes — they can be injected at the same time or separately. Some people combine them in the same syringe (both are typically water-soluble at research doses), though separate injections are safer practice.
Q: How long before I notice results?
A: GHK-Cu changes are gradual — skin quality improvements show up around 4–6 weeks. Tendon/collagen improvements take longer (8–12+ weeks). MOTS-C energy effects can be noticeable within 2–4 weeks for some people, though individual response varies.
Q: Is this safe to run long-term?
A: Both peptides are analogs of naturally occurring compounds your body already produces. The community data on long-term use is generally positive. GHK-Cu levels naturally decline with age; supplementing them back toward youthful levels is the rationale for long-term use.
Q: What injection sites work for these?
A: Lower abdomen, outer thigh, or flank are all standard subQ injection sites. Rotate to avoid tissue buildup.
Q: Do I need to cycle either peptide?
A: GHK-Cu can be run continuously. MOTS-C is typically run in cycles (8–12 weeks on, 4 weeks off) to prevent receptor downregulation, though some people run it continuously at lower doses. Community practice varies.
---
Track Your Stack with PeptIQ
Managing multiple daily peptide injections, tracking your training response, and knowing when to adjust dosing gets complicated fast — especially when you're running a stack.
PeptIQ lets you log every injection, set reminders, track training metrics, and monitor how your body responds over time. Built for serious peptide researchers who want data, not guesswork.
Download PeptIQ — Premium; annual includes a 3-day trial.